Back to top

Hold Rating for Ventyx Biosciences Amid Promising Early Data and Strategic Uncertainties

Morgan Stanley analyst Vikram Purohit has maintained their neutral stance on VTYX stock, giving a Hold rating yesterday. Vikram Purohit’s rating is...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Ventyx Biosciences, Inc. (VTYX)